|
|
|
Dr Eliza Whiteside
Bone Biology Group, Tissue BioRegeneration and Innovation Program, Science Research Centre
Queensland University of Technology
Brisbane, Qld 4001
Email: e.whiteside@qut.edu.au
Tel: +61-7-3864-9254
Fax: +61-7-3864-1534
Homepage:
| Research |
| Our group’s research focus is to establish a bioactive coating that encourages osseointegration of orthopaedic implants. We collect bone marrow samples from patients undergoing hip or knee replacements and utilising a magnetic separation technique (VarioMACS, MiltenyiBiotec) isolate mesenchymal stem cells and osteo-progenitor cells. My specific interest is investigating metalloproteases (MMPs and ADAMs) and their biological inhibitors (TIMPs) and their roles as extracellular matrix (ECM) degraders and activators of growth factors and cytokines during osseointegration and bone remodelling. |
|
| Collaborations |
|
|
| Publications |
Whiteside EJ, Jackson MM, Herington AC, Edwards DR, Harvey MB. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos. Biol Reprod. 2001 May;64(5):1331-7.
Whiteside EJ, Kan M, Jackson MM, Thompson JG, McNaughton C, Herington AC, Harvey MB. Urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9(MMP-9) expression and activity during early embryo development in the cow. Anat Embryol (Berl). 2001 Dec;204(6):477-83.
|
|
|
|
|
|
|
|
|
